Further advances in genomics and proteomics platforms, as well as biomarker assay techniques, have resulted in the identification of a variety of novel biomarkers, including GP-73, GPC-3, OPN, and microRNAs, that have improved HCC diagnosis [71]. Here, GPC3 is linked to hepatocellular carcinoma.